Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Activating PPAR-γ signalling can protect hair follicle stem cells from damage caused by chemotherapy.

Both azathioprine and betamethasone treatments help with hair regrowth in alopecia areata, but azathioprine may have fewer side effects.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

Inhibiting ornithine decarboxylase may help prevent certain skin cancers.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

Compound 15a was effective in inhibiting 5α-reductase.

Retinoids can help treat skin pigmentation disorders by affecting melanin production.

Two new compounds were found to effectively reduce hair growth in mice.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

CAP7.1 is generally safe at 200 mg/m²/day, but can cause fatigue, nausea, hair loss, fever, and blood-related issues.

Sacituzumab Tirumotecan shows promise in treating gynecologic cancers with manageable side effects.

Mimosine dipeptides are promising for treating hyperpigmentation and inflammation.

Temozolomide can cause severe bone marrow suppression, leading to life-threatening complications.

Trilostane treatment led to full hair regrowth in most Pomeranians and all miniature poodles with alopecia X.

Some thymic peptides can increase human hair growth, while others may inhibit it.

The patient's symptoms improved with treatment but recurred when the steroid dose was reduced, requiring ongoing therapy.

Enzyme replacement therapy improved multiple symptoms of homocystinuria in mice.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

The MDR1 C3435T polymorphism does not significantly affect methotrexate response in rheumatoid arthritis patients.

Allopregnanolone increases growth and changes gene activity in human brain cancer cells.

Modifying steroidal inhibitors shows promise for developing new cancer treatments.

Loss of Dnmt3a and Dnmt3b leads to more aggressive skin tumors, but blocking PPAR-γ can reduce this effect.

Methotrexate effectively managed SAPHO syndrome symptoms when other treatments failed.

The new platinum complexes effectively increased survival in rats with tumors, despite some reversible side effects.

Methotrexate therapy for psoriasis may help regrow hair in some cases of male pattern baldness.

Promising cancer treatments were found, but the manufacturer closed.

Some existing medicines show promise as safe treatments to protect against the side effects of radiation therapy.

Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.